Anaesthesia in Orthopaedic: Optimize Safety & Outcomes

Comprehensive Introduction to Orthopaedic Anaesthesia

The orthopaedic patient population presents a uniquely complex and diverse array of physiological challenges that demand meticulous perioperative management. This demographic spans the absolute extremes of age, from neonates requiring correction of congenital deformities to the frail geriatric population presenting with fragility fractures and a myriad of embedded medical comorbidities. Furthermore, the surgical pathology itself dictates a wide spectrum of interventions, ranging from minimally invasive, day-case arthroscopic procedures to massive, multi-level spinal deformity corrections and complex pelvic trauma reconstructions that severely test the physiological reserve of the individual patient. Consequently, the modern practice of orthopaedic anaesthesia has evolved far beyond the mere provision of intraoperative unconsciousness; it is now a comprehensive subspecialty of perioperative medicine focused on optimizing physiological parameters, mitigating surgical stress, and facilitating rapid functional recovery.

Due to these inherent complexities, an individual anaesthetic plan must be highly customized to the specific medical demands of the patient, the precise requirements of the surgical technique, and the logistical limitations of the institution in which the surgery occurs. The orthopaedic surgeon and the anaesthesiologist must operate as a cohesive unit, engaging in shared decision-making regarding patient positioning, tourniquet application, blood conservation strategies, and postoperative pain management. The physiological insults of orthopaedic surgery—such as massive fluid shifts, substantial occult blood loss, and the systemic inflammatory response triggered by extensive bone and soft tissue dissection—require an anaesthetic approach that proactively anticipates and manages hemodynamic lability.

The advent of Enhanced Recovery After Surgery (ERAS) protocols has fundamentally paradigm-shifted the approach to orthopaedic anaesthesia. Historically, prolonged fasting, heavy reliance on opioid analgesia, and delayed mobilization were standard practices that inadvertently contributed to postoperative morbidity, including ileus, delirium, and venous thromboembolism. Today, the integration of multimodal analgesia, regional anaesthetic techniques, goal-directed fluid therapy, and early enteral nutrition has drastically reduced the length of hospital stays and improved patient-reported outcomes. This multidisciplinary approach relies heavily on the anaesthesiologist's ability to blunt the neuroendocrine stress response while preserving motor function to allow for immediate postoperative physical therapy.

Furthermore, the integration of advanced monitoring technologies and ultrasound-guided regional anaesthesia has drastically improved the safety profile of orthopaedic procedures. However, the increasing complexity of both the surgical interventions and the patient population necessitates a profound understanding of cardiopulmonary pathophysiology, neuroanatomy, and pharmacology. The definitive goal of orthopaedic anaesthesia is to synthesize these disciplines, providing a seamless continuum of care that minimizes perioperative risk, maximizes surgical exposure and safety, and accelerates the patient's return to baseline functional status.

Physiological Principles and Pharmacological Biomechanics

The pathophysiology of surgical stress in orthopaedic interventions is characterized by a profound neuroendocrine and inflammatory cascade. Tissue trauma from surgical incision, osteotomy, and intramedullary reaming stimulates nociceptive pathways that ascend via the spinothalamic tracts, triggering the hypothalamus and pituitary gland. This results in a massive surge of catecholamines, cortisol, and glucagon, leading to a hypermetabolic state characterized by tachycardia, hypertension, hyperglycemia, and increased oxygen consumption. Concurrently, the localized release of cytokines (such as IL-1, IL-6, and TNF-alpha) promotes a systemic inflammatory response and a state of hypercoagulability. Effective anaesthetic management, particularly through the use of neuraxial and peripheral nerve blockades, can preemptively interrupt these afferent nociceptive signals, thereby significantly blunting the catabolic stress response and reducing the incidence of postoperative complications.

Tourniquet physiology represents a critical biomechanical and physiological consideration unique to orthopaedic surgery. While pneumatic tourniquets provide a bloodless surgical field, their application and subsequent deflation induce significant systemic alterations. Inflation beyond 60 minutes leads to progressive tissue hypoxia, anaerobic metabolism, and the accumulation of lactic acid, potassium, and carbon dioxide in the ischemic limb. This localized ischemia can also trigger "tourniquet pain," a dull, aching sensation mediated by unmyelinated C-fibers that can break through standard regional or general anaesthesia, manifesting as unexplained tachycardia and hypertension. Upon deflation, the sudden release of these accumulated metabolites into the systemic circulation causes a transient but potentially severe metabolic acidosis, hypercapnia, and a precipitous drop in core body temperature and central venous pressure, requiring vigilant hemodynamic monitoring and compensatory ventilation strategies by the anaesthesia team.

Bone Cement Implantation Syndrome (BCIS) is a potentially catastrophic physiological event associated with the use of polymethyl methacrylate (PMMA) cement, most commonly during hip and knee arthroplasty. The pathophysiology is multifactorial, involving both the mechanical embolization of fat, marrow, and air into the venous circulation during the pressurization of the medullary canal, as well as the systemic vasodilatory effects of the volatile unpolymerized methyl methacrylate monomer. Clinically, BCIS manifests as sudden-onset hypoxia, hypotension, pulmonary hypertension, right ventricular strain, and, in severe cases, cardiovascular collapse and cardiac arrest. Mitigation strategies require close communication between the surgeon and anaesthesiologist, ensuring adequate intravascular volume loading prior to cementation, maximizing the inspired oxygen fraction (FiO2), and utilizing meticulous surgical techniques such as thorough medullary lavage and venting.

Fat Embolism Syndrome (FES) is another critical pathophysiological entity, primarily associated with long bone fractures and intramedullary nailing. The mechanical theory postulates that increased intramedullary pressure forces macroscopic fat droplets into the torn venous sinusoids, which then embolize to the pulmonary capillary bed. The biochemical theory suggests that plasma mediators induce the coalescence of chylomicrons into larger fat globules, triggering a systemic inflammatory cascade and endothelial damage. FES typically presents 24 to 72 hours post-injury with a classic triad of respiratory distress (hypoxemia, ARDS), neurological dysfunction (confusion, altered sensorium), and a petechial rash (typically over the thorax, axillae, and conjunctivae). Anaesthetic management focuses on early operative stabilization of fractures to reduce the embolic load, supportive mechanical ventilation, and maintaining optimal hemodynamics to support right ventricular function.

Exhaustive Indications and Contraindications for Anaesthetic Modalities

The selection of an anaesthetic modality—General Anaesthesia (GA), Neuraxial Anaesthesia (Spinal/Epidural), or Peripheral Nerve Blocks (PNBs)—is a highly nuanced decision predicated on patient comorbidities, surgical site, anticipated duration, and patient preference. General anaesthesia remains the modality of choice for procedures involving the airway, prolonged surgeries of the upper extremity or spine, and in patients who absolutely refuse regional techniques or possess contraindications to them. GA provides secure airway control, precise regulation of ventilation, and profound muscle relaxation, which is often essential for fracture reduction and complex joint reconstructions. Furthermore, the use of Total Intravenous Anaesthesia (TIVA) with propofol and remifentanil has become increasingly popular in spine surgery, as it preserves somatosensory and motor evoked potentials (SSEPs and MEPs) far better than volatile halogenated agents.

Neuraxial anaesthesia, encompassing spinal and epidural techniques, is widely considered the gold standard for lower extremity arthroplasty, pelvic surgery, and lower extremity trauma. By injecting local anaesthetic into the subarachnoid or epidural space, profound sensory and motor blockade is achieved alongside a beneficial sympathectomy. The physiological advantages of neuraxial anaesthesia in orthopaedics are well-documented: it significantly reduces intraoperative blood loss by lowering mean arterial pressure and venous pressure at the surgical site, decreases the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) by attenuating the hypercoagulable stress response and improving lower limb rheology, and provides superior early postoperative analgesia. Additionally, avoiding endotracheal intubation reduces the risk of postoperative pulmonary complications, particularly in patients with chronic obstructive pulmonary disease (COPD) or severe asthma.

Peripheral Nerve Blocks (PNBs) have revolutionized orthopaedic anaesthesia by providing targeted, site-specific analgesia with minimal systemic side effects. Utilizing real-time ultrasound guidance, anaesthesiologists can precisely deposit local anaesthetic adjacent to specific nerve plexuses or terminal branches. For upper extremity surgery, interscalene blocks are ideal for shoulder and proximal humerus procedures, while supraclavicular or axillary blocks are utilized for elbow, forearm, and hand surgeries. In the lower extremity, there has been a paradigm shift from femoral nerve blocks to adductor canal blocks for total knee arthroplasty; the latter provides excellent analgesia by targeting the saphenous nerve while sparing the motor fibers of the quadriceps, thereby facilitating early ambulation and reducing the risk of postoperative falls.

Despite their advantages, regional and neuraxial techniques carry specific contraindications that must be rigorously respected. Absolute contraindications include patient refusal, localized infection at the injection site, uncorrected severe hypovolemia, and clinically significant coagulopathy. Relative contraindications require a careful risk-benefit analysis; for example, pre-existing peripheral neuropathies (e.g., severe diabetic neuropathy) may be exacerbated by PNBs, and severe stenotic valvular heart disease (e.g., critical aortic stenosis) makes the abrupt sympathectomy and afterload reduction of a spinal anaesthetic highly dangerous.

Pre-Operative Assessment, Fasting Protocols, and Patient Optimization

Preoperative assessment is the cornerstone of perioperative safety, functioning as a systematic process to evaluate the relevance, severity, and optimal treatment of existing medical pathologies prior to surgical intervention. The primary objective is not merely to "clear" a patient for surgery, but to risk-stratify and optimize their physiological status, thereby mitigating the probability of adverse perioperative events, including myocardial infarction, stroke, and mortality. This involves a comprehensive review of cardiovascular, pulmonary, and endocrine systems, utilizing validated risk assessment tools such as the Revised Cardiac Risk Index (RCRI) or the ACS NSQIP surgical risk calculator. Furthermore, factors specific to anaesthesia, such as a thorough airway examination (assessing Mallampati classification, thyromental distance, and cervical spine mobility) are critical, especially in patients with rheumatoid arthritis or ankylosing spondylitis who may present with severe airway challenges.

Fasting guidelines are a critical component of preoperative preparation, designed to minimize the volume and acidity of gastric contents, thereby reducing the risk of pulmonary aspiration during the induction of anaesthesia. In elective orthopaedic surgery, standard local fasting times must be strictly adhered to. A typical evidence-based regimen follows the 6-4-2 rule, which is detailed in Table 1.1 below. It is crucial to note that "solid food" includes milk and fresh fruit juices with pulp. Conversely, contemporary ERAS protocols emphasize that it is not only safe but highly beneficial for patients (including well-controlled diabetics) to consume specialized carbohydrate-rich (maltodextrin) clear fluids up to 2 hours before elective surgery. This practice significantly improves subjective patient well-being, reduces preoperative thirst, hunger, and anxiety, and critically blunts postoperative insulin resistance and protein catabolism.

In the context of orthopaedic trauma, the physiological parameters governing gastric emptying are profoundly altered. Gastric motility is essentially halted from the exact moment of injury due to the massive surge in sympathetic nervous system tone. This gastroparesis is further exacerbated and prolonged by the administration of exogenous opiate analgesics required for pain control. Consequently, standard fasting times are notoriously difficult to interpret and highly unreliable in trauma patients. The fasting duration must be calculated from the time of the last oral intake to the time of the traumatic injury, rather than the time of surgery. All trauma patients must be treated as having a "full stomach," necessitating specific anaesthetic precautions such as a Rapid Sequence Induction (RSI) with the application of cricoid pressure to prevent passive regurgitation.

Patient optimization extends beyond fasting and airway assessment to include the meticulous management of chronic medications. Anticoagulants and antiplatelet agents present a frequent challenge in orthopaedics. The anaesthesiologist must balance the risk of surgical bleeding and neuraxial hematoma against the risk of thromboembolic events if the medications are withheld. Guidelines from the American Society of Regional Anesthesia and Pain Medicine (ASRA) dictate precise timeframes for the cessation and resumption of these agents relative to neuraxial blockade. Additionally, the optimization of preoperative anemia—often via intravenous iron infusions or erythropoietin-stimulating agents—is vital to reduce the reliance on allogeneic blood transfusions, which carry inherent risks of immunomodulation and infection.

Step-by-Step Intraoperative Techniques and Regional Blockade

The execution of General Anaesthesia for orthopaedic procedures requires a meticulously orchestrated sequence of pharmacological interventions. Induction is typically achieved with intravenous agents such as propofol, which provides rapid loss of consciousness and profound suppression of airway reflexes, facilitating endotracheal intubation or laryngeal mask airway (LMA) placement. In hemodynamically unstable trauma patients, ketamine or etomidate may be preferred due to their superior cardiovascular stability. Maintenance of anaesthesia is generally achieved via volatile halogenated ethers (e.g., sevoflurane, desflurane) combined with opioid analgesics and neuromuscular blocking agents. However, in complex spine surgeries requiring neuromonitoring, a Total Intravenous Anaesthesia (TIVA) technique utilizing continuous infusions of propofol and remifentanil is mandated, as volatile agents cause dose-dependent suppression of evoked potential amplitudes and increased latencies, rendering intraoperative neurological monitoring unreliable.

Neuraxial blockade, specifically spinal anaesthesia, involves the precise deposition of local anaesthetic into the subarachnoid space, typically at the L3-L4 or L4-L5 interspace to avoid trauma to the conus medullaris. The patient is positioned in either the lateral decubitus or sitting position, and under strict aseptic technique, a fine-gauge (e.g., 25G or 27G) pencil-point needle is advanced through the ligamentum flavum and dura mater. Once free-flowing cerebrospinal fluid (CSF) is confirmed, a hyperbaric or isobaric solution of bupivacaine or ropivacaine is injected. The addition of lipophilic opioids, such as fentanyl, enhances the quality and duration of the sensory block without significantly prolonging motor blockade, while hydrophilic opioids like preservative-free morphine can provide up to 24 hours of profound postoperative analgesia, albeit with a risk of delayed respiratory depression that requires vigilant postoperative monitoring.

The application of ultrasound-guided Peripheral Nerve Blocks (PNBs) requires a deep understanding of cross-sectional sonoanatomy and precise needle control. For an interscalene block, utilized for shoulder surgery, the high-frequency linear ultrasound probe is placed transversely across the neck to identify the brachial plexus roots (C5-C7) sandwiched between the anterior and middle scalene muscles. Local anaesthetic is carefully deposited within the fascial sheath, taking extreme care to avoid intravascular injection into the adjacent vertebral or carotid arteries, and avoiding the phrenic nerve, which can lead to hemidiaphragmatic paresis. For hand and wrist surgery, the axillary block targets the terminal branches of the brachial plexus (radial, ulnar, median, and musculocutaneous nerves) surrounding the axillary artery, providing excellent surgical anaesthesia while avoiding the risk of pneumothorax associated with supraclavicular approaches.

In the lower extremity, the evolution of regional techniques has focused heavily on maximizing analgesia while facilitating early rehabilitation. The adductor canal block has largely superseded the traditional femoral nerve block for total knee arthroplasty. Using ultrasound, the adductor canal is identified in the mid-thigh, deep to the sartorius muscle and adjacent to the superficial femoral artery. Local anaesthetic is injected to bathe the saphenous nerve and the nerve to the vastus medialis. Because this technique largely spares the major motor branches of the femoral nerve that innervate the quadriceps, patients maintain knee extension strength. This dramatically reduces the incidence of postoperative buckling and falls, allowing physical therapy to commence within hours of surgery, a cornerstone of modern orthopaedic ERAS pathways.

Complications, Incidence Rates, and Salvage Management in Anaesthesia

While modern anaesthetic techniques are exceptionally safe, the inherent physiological perturbations and pharmacological interventions carry specific risks that require immediate recognition and aggressive salvage management. Local Anaesthetic Systemic Toxicity (LAST) is a rare but potentially fatal complication of regional anaesthesia, occurring when a toxic dose of local anaesthetic enters the systemic circulation, either via inadvertent intravascular injection or rapid systemic absorption from highly vascular tissue beds. The pathophysiology involves the blockade of voltage-gated sodium channels in the central nervous system and myocardium. Clinically, LAST presents with a prodrome of perioral numbness, metallic taste, tinnitus, and agitation, which can rapidly progress to generalized tonic-clonic seizures, profound bradycardia, ventricular arrhythmias, and intractable cardiovascular collapse.

The salvage management of LAST requires an immediate, protocolized response. The injection of local anaesthetic must be halted instantly, and the airway secured with 100% oxygen to prevent hypoxia and acidosis, which exacerbate local anaesthetic toxicity. Seizures should be controlled with benzodiazepines; propofol must be strictly avoided as it is a cardiovascular depressant. The definitive treatment is the rapid administration of 20% Intravenous Lipid Emulsion (Intralipid). The lipid emulsion acts as a "lipid sink," sequestering the highly lipophilic local anaesthetic molecules away from myocardial and cerebral tissues, while also providing a direct metabolic substrate to the poisoned myocardium. Cardiopulmonary resuscitation may need to be prolonged, and standard Advanced Cardiac Life Support (ACLS) protocols must be modified to avoid vasopressin and use reduced doses of epinephrine.

Neuraxial anaesthesia complications, though infrequent, can result in significant long-term morbidity. Post-Dural Puncture Headache (PDPH) occurs due to the leakage of CSF through the dural puncture site, leading to intracranial hypotension and traction on pain-sensitive meningeal structures. It presents as a severe, positional fronto-occipital headache that worsens upon standing. Conservative management includes hydration, caffeine, and simple analgesics; refractory cases are treated definitively with an epidural blood patch. A far more devastating complication is an epidural hematoma, which can compress the spinal cord leading to irreversible paraplegia. It presents as severe, unremitting back pain and progressing lower extremity motor and sensory deficits. Immediate salvage requires an urgent MRI to confirm the diagnosis, followed by emergent surgical decompressive laminectomy within 6 hours of symptom onset to maximize the chance of neurological recovery.

Malignant Hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle triggered by volatile anaesthetics (e.g., sevoflurane, desflurane) and the depolarizing neuromuscular blocker succinylcholine. It is characterized by an uncontrolled release of intracellular calcium from the sarcoplasmic reticulum via a defective ryanodine receptor (RYR1). This results in a massive hypermetabolic state. Clinical signs include an abrupt and unexplained rise in end-tidal carbon dioxide (EtCO2), masseter muscle rigidity, generalized muscle rigidity, profound metabolic and respiratory acidosis, hyperkalemia, and a rapidly rising core temperature (a late sign). Immediate management involves discontinuing the triggering agents, hyperventilating with 100% oxygen, and the rapid, continuous administration of intravenous Dantrolene, a direct-acting muscle relaxant that binds the ryanodine receptor and halts calcium release.

Phased Post-Operative Rehabilitation Protocols

The immediate postoperative phase is a critical window where the anaesthetic plan seamlessly transitions into the rehabilitation protocol. The foundation of modern postoperative care in orthopaedics is multimodal analgesia. This strategy utilizes multiple pharmacological agents that target different receptors along the nociceptive pathway, thereby providing superior pain relief while minimizing the dose-dependent side effects of any single drug, particularly opioids. A standard multimodal regimen includes the scheduled administration of acetaminophen (paracetamol), non-steroidal anti-inflammatory drugs (NSAIDs) or selective COX-2 inhibitors (e.g., celecoxib) to reduce peripheral inflammation, gabapentinoids (e.g., pregabalin) to modulate neuropathic pain signals, and the continuation of regional nerve blocks. This opioid-sparing approach drastically reduces the incidence of postoperative nausea, vomiting, sedation, and respiratory depression, which are major barriers to early mobilization.

Enhanced Recovery After Surgery (ERAS) protocols dictate a highly structured, phased approach to postoperative rehabilitation. Phase I begins in the Post-Anaesthesia Care Unit (PACU), focusing on the rapid clearance of anaesthetic agents, strict hemodynamic control, and the verification of adequate pain control without excessive motor blockade. Phase II commences upon transfer to the surgical ward, where the emphasis shifts entirely to early, aggressive mobilization. In total joint arthroplasty, patients are frequently assisted to stand and walk within hours of surgery. This early mechanical loading stimulates osteoblast activity around implants, improves venous return to mitigate DVT risk, and prevents the rapid deconditioning associated with bed rest. The anaesthesiologist's role in this phase is to ensure that continuous peripheral nerve catheters or patient-controlled analgesia (PCA) modalities are functioning optimally to permit this physical therapy.

Postoperative Nausea and Vomiting (PONV) is a highly distressing complication that can delay discharge, cause dehydration, and lead to wound dehiscence or bleeding due to increased intrathoracic pressure. Risk stratification utilizing the Apfel score (female gender, non-smoker, history of PONV/motion sickness, and postoperative opioid use) guides prophylactic management. High-risk orthopaedic patients should receive combination antiemetic therapy, typically involving a 5-HT3 receptor antagonist (e.g., ondansetron) administered at the end of surgery, combined with dexamethasone given at induction. In refractory cases, rescue therapy with agents from different pharmacological classes, such as dopamine antagonists (e.g., droperidol) or neurokinin-1 receptor antagonists, is necessary to ensure the patient can tolerate early enteral feeding, a key tenet of ERAS.

Venous Thromboembolism (VTE) prophylaxis is an absolute necessity in orthopaedic surgery, given the high-risk nature of procedures involving the pelvis and lower extremities. The regimen typically involves a combination of mechanical prophylaxis (intermittent pneumatic compression devices) and pharmacological agents (low molecular weight heparins, direct oral anticoagulants, or aspirin). The anaesthesiologist must meticulously coordinate the timing of pharmacological VTE prophylaxis with the removal of indwelling epidural or peripheral nerve catheters. Strict adherence to ASRA guidelines is mandatory; for example, the removal of an epidural catheter must occur at least 12 hours after the last dose of prophylactic enoxaparin, and the subsequent dose cannot be administered until at least 4 hours post-removal, ensuring the risk of an epidural hematoma is minimized during the vulnerable period of catheter withdrawal.

Summary of Landmark Literature and Clinical Guidelines

The practice of orthopaedic anaesthesia is heavily dictated by rigorous, evidence-based guidelines and landmark clinical trials. The American Society of Regional Anesthesia and Pain Medicine (ASRA) guidelines on Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy represent the definitive text governing the safe performance of neuraxial and deep peripheral nerve blocks. These guidelines provide exhaustive, drug-specific timeframes for the cessation of anticoagulants prior to block placement and the safe re-initiation of therapy post-procedure, fundamentally shaping how anaesthesiologists interact with the increasingly complex cardiovascular medication profiles of the modern orthopaedic patient.

Furthermore, the PROSPECT (Procedure-Specific Postoperative Pain Management) working group provides highly specific, evidence-based recommendations for pain management tailored to individual orthopaedic procedures. By analyzing the available literature, PROSPECT guidelines delineate the optimal combination of systemic analgesics, local infiltration techniques (such as periarticular injections in knee arthroplasty), and regional blocks. These guidelines have been instrumental in standardizing care, demonstrating that a generic approach to pain management is inferior to a procedure-specific, multimodal strategy in reducing opioid consumption and accelerating functional recovery.

Recent landmark literature has also challenged long-held dogmas regarding anaesthetic choice. The REGAIN (Regional versus General Anesthesia for Promoting Independence after Hip Fracture) trial, a massive randomized controlled trial, rigorously compared spinal anaesthesia to general anaesthesia in older adults undergoing hip fracture surgery. Surprisingly, the trial demonstrated no significant difference in the primary outcome of survival and recovery of ambulation at 60 days, nor in the incidence of postoperative delirium. Such high-quality data forces clinicians to continually re-evaluate their practices, suggesting that meticulous intraoperative physiological management and comprehensive postoperative care may be more critical determinants of outcome than the specific anaesthetic modality chosen.

Looking forward, the literature is rapidly expanding into the realms of predictive analytics and novel pharmacological delivery systems. The use of artificial intelligence and machine learning algorithms to predict individual patient trajectories for postoperative pain and PONV is beginning to allow